These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2486748)

  • 1. Efficacy of various methods of confidential unit exclusion in identifying potentially infectious blood donations.
    Loiacono BR; Carter GR; Carter CS; Leitman SF; Klein HG
    Transfusion; 1989; 29(9):823-6. PubMed ID: 2486748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of 6 years of confidential unit exclusion at the Belgian Red Cross Flanders Blood Service.
    Vandewalle G; Baeten M; Bogaerts K; Vandekerckhove P; Compernolle V
    Vox Sang; 2014 May; 106(4):354-60. PubMed ID: 24289738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the confidential unit exclusion form: the Canadian Blood Services experience.
    O'Brien SF; Fan W; Xi G; Yi QL; Goldman M
    Vox Sang; 2010 Feb; 98(2):138-44. PubMed ID: 19754523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of simple donor education on donor behavioral deferral and infectious disease rates in São Paulo, Brazil.
    Gonçalez TT; Sabino EC; Salles NA; de Almeida-Neto C; Mendrone A; Dorlhiac-Laccer PE; Liu J; Murphy EL; Schreiber GB;
    Transfusion; 2010 Apr; 50(4):909-17. PubMed ID: 20003056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demographic characteristics and prevalence of serologic markers among blood donors who use confidential unit exclusion (CUE) in São Paulo, Brazil: implications for modification of CUE policies in Brazil.
    de Almeida-Neto C; Liu J; Wright DJ; Mendrone-Junior A; Takecian PL; Sun Y; Ferreira JE; de Alencar Fischer Chamone D; Busch MP; Sabino EC;
    Transfusion; 2011 Jan; 51(1):191-7. PubMed ID: 20663108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor selection: the exclusion of high risk donors?
    van den Burg PJ; Vrielink H; Reesink HW
    Vox Sang; 1998; 74 Suppl 2():499-502. PubMed ID: 9704489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computer interview for screening blood donors for risk of HIV transmission.
    Locke SE; Kowaloff HB; Hoff RG; Safran C; Popovsky MA; Cotton DJ; Finkelstein DM; Page PL; Slack WV
    MD Comput; 1994; 11(1):26-32. PubMed ID: 8145632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of HIV-1 in blood donations following implementation of a structured blood safety policy in South Africa.
    Heyns Adu P; Benjamin RJ; Swanevelder JP; Laycock ME; Pappalardo BL; Crookes RL; Wright DJ; Busch MP
    JAMA; 2006 Feb; 295(5):519-26. PubMed ID: 16449617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Donor exclusions, discarded blood and transfusion unsuited blood conserves of 2,13 million potential blood donors 1991 to 1994].
    Diekamp U; Wehrend W; Marklof E; Kamutzky K
    Beitr Infusionsther Transfusionsmed; 1996; 33():81-92. PubMed ID: 8974711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimates of infectious disease risk factors in US blood donors. Retrovirus Epidemiology Donor Study.
    Williams AE; Thomson RA; Schreiber GB; Watanabe K; Bethel J; Lo A; Kleinman SH; Hollingsworth CG; Nemo GJ
    JAMA; 1997 Mar; 277(12):967-72. PubMed ID: 9091668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective surveillance of HIV prevalence in blood donors can help in the selection of the best social group for blood donation in Mali.
    Tounkara A; Diakite M; Noumsi GT; Sarro YD; Siddiqui S; Parta M
    Transfus Med; 2009 Oct; 19(5):252-9. PubMed ID: 19747288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimated rate of HIV-1-infectious but seronegative blood donations in Bangkok, Thailand.
    Kitayaporn D; Kaewkungwal J; Bejrachandra S; Rungroung E; Chandanayingyong D; Mastro TD
    AIDS; 1996 Sep; 10(10):1157-62. PubMed ID: 8874634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epidemiology of HIV transmission among paid plasma donors, Mexico City, Mexico.
    Avila C; Stetler HC; Sepúlveda J; Dickinson E; Castro KG; Ward JW; Romero G; Valdespino JL
    AIDS; 1989 Oct; 3(10):631-3. PubMed ID: 2512956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current impact of the confidential unit exclusion option.
    Zou S; Notari EP; Musavi F; Dodd RY;
    Transfusion; 2004 May; 44(5):651-7. PubMed ID: 15104644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of donor self exclusion in repeat blood donors].
    Pastucha L; Andres J; Stangel W
    Beitr Infusionsther; 1990; 26():5-8. PubMed ID: 1703899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the confidential unit exclusion on Iranian blood donors: An 11-year experience.
    Ameli MR; Hosseini SH; Rad F; Sajjadi SM
    Asian J Transfus Sci; 2021; 15(1):57-61. PubMed ID: 34349458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of the confidential unit exclusion option.
    Petersen LR; Lackritz E; Lewis WF; Smith DS; Herrera G; Raimondi V; Aberle-Grasse J; Dodd RY
    Transfusion; 1994 Oct; 34(10):865-9. PubMed ID: 7940657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Questionable efficacy of confidential unit exclusion.
    Busch MP; Perkins HA; Holland PV; Doll LS; Petersen L
    Transfusion; 1990 Sep; 30(7):668-9. PubMed ID: 2402781
    [No Abstract]   [Full Text] [Related]  

  • 19. Confidential donation confirmation as an alternative to confidential unit exclusion: 15 months experience of the HEMOMINAS foundation.
    Loureiro FC; Oliveira CD; Proietti AB; Proietti FA
    Rev Bras Hematol Hemoter; 2011; 33(4):263-7. PubMed ID: 23049316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing confidential unit exclusions in blood donors.
    Sümnig A; Konerding U; Kohlmann T; Greinacher A
    Vox Sang; 2010 Apr; 98(3 Pt 1):e231-40. PubMed ID: 19765268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.